PepJunkie Home of the Peptonauts
More

Peptide Atlas · Peptide

Triptorelin

Triptorelin is a gonadotropin-releasing hormone analogue; in 66 children treated with slow-release triptorelin for central precocious puberty, final height matched the genetic target, and girls gained 4.8 cm over their predicted height.

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Triptorelin. Tier reflects study design, not enthusiasm.
ClaimTierSource
Final height after long-term triptorelin for central precocious pubertyemergingpmid 10372696
Triptorelin during chemotherapy and early menopause in breast cancer (phase 3 RCT)establishedpmid 21771987

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.